Cathie Wood’s ARK sells Bullish stock, buys more 10X Genomics

Investing.com•Tuesday, March 24, 2026 at 12:08:43 AM

NeutralFinancial Markets

Cathie Wood’s ARK sells Bullish stock, buys more 10X Genomics

What Happened
Cathie Wood's ARK Investment Management has sold its shares in Bullish stock and increased its investment in 10X Genomics, indicating a strategic shift in its portfolio. This decision aligns with ARK's focus on companies that are positioned for growth in the genomics sector.
Why It Matters
The acquisition of more shares in 10X Genomics suggests that ARK is optimistic about the company's potential, reflecting a broader trend in the investment community towards innovative biotech firms that are expected to drive future advancements in healthcare.
The Bigger Picture
This move is part of a series of adjustments by ARK, which has recently sold stakes in other companies like Guardant Health and Teradyne, showcasing a proactive approach to capitalizing on emerging opportunities while navigating the evolving market landscape.

— via World Pulse Now AI Editorial System

Read Original

Was this article worth reading? Share it

Ticker Nerd Crypto

Discover early-stage crypto coins with 100x potential through our monthly data-driven reports.

Finance & CryptoView app details

Crypto OS ⚡

Track, manage, and grow your on-chain income from a single dashboard.

Tech & Developer ToolsView app details

Revscale.ai

Your AI co-founder for B2B growth, strategy, and scaling operations.

AI & DataView app details

Xgager

Connect and engage effectively on X with meaningful conversations.

AI & DataView app details

SparrowGenie

Automate sales outreach and follow-ups with AI-powered personalization and efficiency.

AI & DataView app details

Northstar Toolkit

AI tools to boost nonprofit impact, efficiency, and fundraising results.

Tech & Developer ToolsView app details

Continue Readings

TheStreet4 hours ago

Cathie Wood sells $40.6 million of popular semiconductor stock

NegativeFinancial Markets

Cathie Wood, CEO of Ark Investment Management, has sold $40.6 million worth of shares in a popular semiconductor stock amid a significant market pullback, with the iShares Semiconductor ETF (SOXX) experiencing a drop of approximately 4% on May 15. This sale reflects her active trading strategy during volatile market conditions.

Read full article

via TheStreet

Investing.com2 days ago

Cathie Wood’s ARK trims Taiwan Semiconductor stock, adds Cerebras

NeutralFinancial Markets

Cathie Wood's ARK Investment Management has reduced its holdings in Taiwan Semiconductor while adding shares of Cerebras, reflecting a strategic shift in its investment approach. This decision aligns with ARK's ongoing adjustments to its portfolio as it seeks to capitalize on emerging technologies and market trends.

Read full article

via Investing.com

TheStreet3 days ago

Cathie Wood trims $3.17M of surging bioscience stock

NeutralFinancial Markets

Cathie Wood's ARK Investment Management has sold $3.17 million worth of shares in Twist Bioscience, continuing its trend of gradually exiting positions in specific stocks. This sale is part of a broader strategy where ARK has been reallocating its investments, as evidenced by recent transactions involving other companies such as Natera and Intellia.

Read full article

via TheStreet

Ready to build your own newsroom?

Subscribe to unlock a personalised feed, podcasts, newsletters, and notifications tailored to the topics you actually care about